摘要
目的:观察分析卡托普利治疗心力衰竭的临床疗效。方法:从本院收治入院的心力衰竭患者中抽取120例,随机分为观察组与对照组,对照组患者实施常规抗心衰治疗,观察组患者在此基础上加用卡托普利治疗,观察两组患者的治疗效果。结果:观察组患者治疗总有效率明显高于对照组,治疗4个月后左室舒张、收缩末期内径减少程度和射血分数明显优于对照组,比较差异有统计学意义(P<0.05)。结论:卡托普利可以有效改善心力衰竭患者左心室舒张、收缩末期内径及射血分数,明显提高对心力衰竭患者的临床治疗效果,具有在临床上进一步推广应用的价值。
Objective： To observe the clinical efficacy of captopril in the treatment of heart failure analysis. Method： To select 120 patients with heart failure from our hospital, who were randomly divided into observation group and control group. The control group implemented routine anti heart failure treatment, and the observation group was treated with captopril on this foundation. To observe the therapeutic effect of the two groups. Result： The observation group＇ s total effective rate of treatment was significantly higher than the control group＇ s. 4 months after the treatment, left ventricular diastolic, systolic diameter reduction degree, and ejection fraction of the observation group was significantly better than that of the control group, and the difference was statistically significant （P〈0.05） . Conclusion： Captopril can improve heart failure patients with left ventricular diastolic, systolic diameter, and ejection fraction, and significantly improve the clinical effect in the treatment of heart failure, and have further extending application value with clinically.
出处
《中国医学创新》
CAS
2013年第15期123-125,共3页
Medical Innovation of China
关键词
卡托普利
心力衰竭
抗心衰治疗
临床效果
Captupril
Heart failure
Heart failure therapy
Clinical effect
